During FDA-declared shortages, pharmacists can legally make compounded versions of brand-name medications. But drugmakers and ...

This proposed rule signals an important shift in the federal approach to obesity management, aligning with the medical ...

Eli Lilly (LLY) emerges among the top performers in Big Pharma in 2024 with obesity drug success, while Novo Nordisk (NVO) ...

Both companies are longtime leaders in the pharmaceutical industry and have been making breakthroughs and delivering ...

By aiding weight loss, Zepbound can improve symptoms of obstructive sleep apnea (OSA) in people with obesity — but CPAP ...

Since the start of 2020, Eli Lilly’s (NYSE: LLY) stock price chart has been straight up and to the right, up 500.39% and ...

GLP-1 receptor agonist weight loss drugs can negatively interact with eating disorder psychopathology and treatment in ...

Tirzepatide may be more effective than semaglutide in helping people lose weight. At least that's the findings from recent ...

Elon Musk has dished the secrets behind his recent weight loss transformation.

Research backs this up: Young men who consumed more protein while losing weight and on an intense exercise regiment gained ...

GLP-1 medications like Semaglutide (found in Ozempic and Wegovy) and Tirzepatide (found in Mounjaro) mimic the body’s natural ...